Safety and Effectiveness of Adding Either an HIV Vaccine, Interleukin-2, or Both to a Patient's Anti-HIV Drug Combination

This study has been completed.

Study NCT00006291 Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

First Received: September 22, 2000 Last Updated: December 19, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	December 2006
Estimated Primary Completion Date:	No date given